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INTRODUCTION 
 
Sinonasal malignancies, a highly heterogeneous group of 
cancers, account for less than one percentage of the cancers and 
less than three percentage of all digeastive system tumors. These 
lesions may originate from any of the histopathologic 
components of the sinonasal cavities, including Schneiderian 
mucosa, minor salivary glands, neural tissue, and lymphatics. 
60%  of these tumors arise in the maxilla, but twenty percentage 
come from cavity of nose, five percentage come from sinus of 
ethimoid, three percentage from the sinus of frontal , sinus of 
sphenoid.  
 
Squamous cell carcinomas are more common within the nasal 
cavity or maxillary sinus, whereas tumors of the ethmoid sinus 
and superior nasal vault are usually adenocarcinomas. 
 
Mucosal melanoma frequently originates within the nasal cavity, 
particularly along the lateral nasal side wall and inferior 
turbinates. Although traditional risk factors for sinonasal cancers 
have included exposure to nickel, wood dust, and tobacco, no 
predisposing factors are identified in most patients. Recent 
reports suggest that HPV promotes the development of some 
sinonasal squamous cancers. 
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Thus the key to the diagnosis and management of sinonasal 
malignancies lies in the eliciting of proper history, clinical 
features and investigation protocol to detect the tumour at the 
early stage and provide the appropriate treatment for the 
patient,thereby increasing the survival rate. 
This study was conducted to assess the importance of detecting 
the clinical features, detecting the lesion through histopathology 
and imaging to arrive at the diagnosis at an earlier stage and 
evaluating the treatment protocol. 
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AIMS OF STUDY 
 
In sinonasal tumours, 
 
1. To correlate the symptoms, signs with the clinical staging. 
2. To correlate the clinical features with the pathological 
staging. 
3. To study the incidence of age and sex of the tumour 
4. To study the incidence of TNM staging and broder’s 
staging among the patients 
5.  To correlate the histological diagnosis and treatment plan. 
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REVIEW OF LITERATURE 
 
In 1826, Lazars described the concept of maxillectomy.                     
In 1828,total maxillectomy along with orbit exenteration was 
first performed and reported by Syme et al. 
 
Sebileau was the person to classify the carcinomas of maxillary 
sinus in 1906. 
 
Sebileau was the person to classify the carcinomas of maxillary 
sinus in 1906. 
In 1927,Portman described sublabial transoral approach   
In 1954,Smith decribed extended maxillectomy. 
In 1943, palatal fenestration with radium therapy was performed 
by Lederman. 
Fairbanks & Barbosa described infratemporal fossa approach for 
advanced  survival maxillary sinus tumors in 1961. 
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In 1963, Sisson  developed TNM classification of antral 
carcinomas. 
In 1963, Sisson  developed TNM classification of antral 
carcinomas. 
In 1981 ,   group of surgeons comprising of St.pierre , Giri , 
Amendola , Ahamed , Jiang conducted a study and found out 
that  there was significant amount of difference between cases 
who were managed with surgery and radiotherapy and cases who 
underwent radiotherapy alone. They inferred that the combined 
modality approach was very better compared to other treatment 
modalities. 
In 1943, Windeyer described deep x-ray exposure followed in 4 
weeks by removal of the palate and alveolus. 
In the same year, Lederman used palatal fenestration with 
intracavitary radium therapy. 
 
In 1952, as advances in surgical techniques, anaesthesia, blood 
replacement and antibiotics reduced, the mortality rate of radical 
maxillectomy, the trend switched to radical surgery combined 
with radiation. 
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Sisson and colleagues in 1963, developed a TNM system for 
classification of antral carcinomas. 
 
Harrison in 1978 developed a staging system based on presence 
of bony erosion with subsequent spread. 
 
Parsons C et al in 1979 reviewed 32 patients with histologically 
proven malignancy of maxilla and studied the CT scans. He 
found certain findings that were present that could to be co 
related with the histology. Thus it was found that even benign 
lesions when present chronically presented similar to a 
malignant growth. Thus CT provided more useful results for 
confirming a malignant growth as for as radiological imaging is 
concerned. 
 
Som PM in 1981 apart from JNA the bowing can occur in any 
lesion which is not invasive and not fast growing in the behind 
maxillary area. Few notable ones are histiocytoma ( fibrous) , 
epithelioma (lympho variant) , schwannomas. 
 
In 1984, Weber AL, and Stanton AC showed that when patients 
presents to the doctor with a sinonasal tumour the time of 
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presentation is usually late. Thus the rate of curing the disease is 
very slow to start by itself. He detailedly analysed the clinical 
presentation and the specific findings in around two hundred 
cases and correlated those inferences with the type of tumour , 
the exact sit of tumour and the exact extention of the tumor. 
 
Johnson et al in 1984, reviewed seventy nine cases with 
sinonasal lesions. Out of seventy nine patients, 47 cases 
presented with evidence of tumour involvement clinically , 
radiographically, and per operative involvement. Mostly it was 
asquamous cell carcinoma only. The other provisional diagnosis 
of sinusitis should be re soughted out again by perforimg 
radiographic imaging and biopsy , mainly in case of eye and 
facial pain.  
 
In 1984 , Larheim compared the frequency in-between bony 
destruction of alveolar process caused to tumours from sinus of 
maxilla , ginigiva , palate. The radiological investigations 
included conventional CT with hypocycloid tomography , 
orthopantomography and computed tomography. The incidence 
of alveolar involvement in maxillary sinus was one in every two 
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of tumour. Other case were alveolar involvement was present are 
gingival and palate. All radiological investigations were highly 
useful in depicting the tuomurs. 3 patients were found to have 
gingival tumour that were found to arise from maxilla. 
 
In 1986, Kondo M, Ando Y did a study on maxillary squamous 
cell carcinomas staged by CT scans. In 72 patients with 
maxillary squamous cell carcinoma, computed tomography (CT) 
alone was used for T-staging according to the AJC classification. 
Five, 31, and 36 tumours were diagnosed as T2, T3, T4, 
respectively. Addition of maxillectomy to treatment seemed to 
have improved the local prognosis in T3 and T4 tumours. High 
radiation doses of 60 Gy or more seemed to be beneficial for 
patients with T3 tumours and without maxillectomy. CT will be 
of great help in classifying tumours objectively. But more 
importantly, it will reveal respectability and dictate treatment of 
choice by delineating the tumour extent precisely. 
 
In 1986, Graber et al demonstrated  CT findings of malignant 
tumours of paranasal sinus in fifteen patients. Non homogenous 
structure were seen in malignant soft tissue tumours. But 
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whether improved radiological diagnosis gave improved 
prognosis of malignant tumours of paranasal sinus. 
A retrospective study was conducted in 1991 by Ben Achour et 
al, fifty two cases of malignant tumours of maxillary sinus.CT 
scans was a great help to assess extension prior  to treatment and 
during follow up. 
In 1995-2001, Padovani et al conducted a study with 25 patients 
with sinonasal undifferentiated carcinoma.All patients were 
subjected to 3D radiotherapy with a dose of 64-70 Gy. 
 
Pera Ramon E et al in 1991, described 2 cases of 
adenocarcinoma of nasal cavities and paranasal sinuses. 
Adenocarcinomas are most often 
seen in the middle turbinate and ethmoid sinus. He reported 2 
cases and discussed its clinical findings, the treatment and 
possible etiologies. 
  
In 1993 , Moriya  K and Sakaguchi M , studied a case of sixty 
year old male patient with a bilateral synchronous carcinoma of 
maxillary sinus. The finding in the CT scan was the came from 
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the left side of maxillary sinus. The right sinus revealed had 
bony walls that were found to be intact. An antrostomy was done 
and a probe was passes into the site and the tumour was found to 
be histlogically the similar type as that of left side ( 
differentiation was poor ). 
 
It was in 1993 , when Ichimura studied about the tumours of the 
head , neck areas which had trismus .About twenty one patients 
who presented with malignant tumours of the two hundred and 
twelve patients with tumours of head and neck. Out of above 
said patients 9 cases developed trismus . It could have been due 
to muscles getting infiltrated by tumour and spasm of the 
muscles. The other causes could be due to radiation in 5 patients. 
But the tumours of maxilla were usually associated without 
trismus even when extent was down to infra temporal area. 
 
Wang P et al in 1997 discussed the CT examination and 
diagnosis of oral and maxillofacial tumour invading 
pterygopalatine fossa. CT findings in 33 cases (proven 
histopathologically) suffered from oral and maxillofacial 
tumours affecting the pterygopalatine space were retrospectively 
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analyzed. The authors conclude that the main CT manifestations 
of this space involvement by tumours can be depicted as a soft 
tissue mass occupancy and the wall structures destruction. 
Tumours occurring in different locations of oral and 
maxillofacial areas have different features of CT appearances. 
As a modality of imaging, CT has an important role for assessing 
the lesions of this fossa. 
 
Ram B, Saleh HA in 1998, described rare case of  carcinoma of 
verrucous carcinoma is a rare type of squamous carcinoma well 
differentiated .The involvement of  maxillary antrum is very 
rare. Previously only 3 patients were documented. 
 
In 2007 december, Ayotunde J Fasunla and Akeen O. Lasisi, 
conducted a study and found out that most common site involved 
is antronaso ethimoidal region for a sinonasal tumor (62%). 
Most common stage of presentation of the disease was STAGE 
III similar to the result of our study. 
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Two cases of adenocarcinomas were studied in 1991, by Pera 
Ramon E et al. They are  most often seen in middle turbinate and 
ethimoid sinus.  
In 2008,Indira madani , Katrien Bonte, Luc Vakaet, Tom 
Boterberg,Wilfried De Neve , studied about the INTENSITY 
MODULATED RADIATION THERAPY for sinonasal tumours 
and concluded that INTENSITY MODULATED radiation 
therapy in cases of tumours in sinonasal cavity had a reduced 
chances of toxicity due to radition hazards with no chances of 
blindness and a high rate of survival and control. 
Stanton AC and Weber AL, in 1984 demonstrated malignant 
tumours involving the paranasal sinuses are at a later stage at the 
time  of presentation of the patient. Two  hundred cases were 
taken and their type, location and extent of spread were studied. 
Second maxillary sinus were studied in 1991 by Shibuya H. 5 
cases with 2nd maxillary sinus carcinoma which was squamous 
type. These  tumours formed after six to seventeen years later to 
the first management of the carcinoma of the opposite side. This 
was correlated to the twenty one patients with the carcinoma 
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primarirly detected via CT scanning. The most specific finding 
in CT scan was  was irregular distribution soft tissue in the 
maxillary sinus antrum and  and the involvement of fragments of 
bone at the initial site.  In five cases the medial bony wall,  the 
bony medial maxillary wall , ethimoid and pterygoids was not 
involved. 
In 2007 december, Ayotunde J Fasunla and Akeen O. Lasisi, 
conducted a study  and found out that most common site 
involved is antronaso ethimoidal region for a sinonasal tumor 
(62%). Most common stage of presentation of the disease was 
STAGE III similar to the result of our study. 
In 1984, Johnson et al studied  seventy nine cases with tumours 
involving the paranasal sinus and nose. 70% of cases who had 
extension in to the orbit was detected with  clinical and 
radiological manifestation in the orbit. Most common frequent 
site was maxillary sinus. In CT scans one should order for the 
base of sinuses for seeing the tumor involvement. 
A sixty eight year old male presented with synchronous bilateral 
carcinomas of maxillary sinus which was studied by Sakaguchi 
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M, Moriya K et al in 1993. The CT scan findings showed a large 
tumour mass from left maxillay sinus. A     tumour was 
diagnosed when a probe antrostomy was as the same poorly 
differentiated carcinoma as that in the left antrum. 
In 2000, Hiroya Ojiri, Masuo Ujita, Shimpei Tada, Khunihiko 
Fukuda conducted a study of potentially distinctive features of 
sinonasal inverted papolloma on MR imaging and concluded that 
the presence of cerebriform pattern with a convoluted 
appearance in T1 weighted ( enhanced) or T2 weighted image 
involving  was inverted papilloma. The presence of  necrosis in 
the tumour indicates accompanying carcinoma. 
In 1995, group of surgeons conducted a clinicopathological 
analysisof eighteen cases of sinonasal malignant melanoma. 
In 1984, Larheim et al, compared incidence of alveolar bone 
palate erosion caused due to carcinoma arising from maxillary 
sinus (31), palate(15), maxillary gingival (9). Every 2nd tumor 
with alveolar bone erosion seemed to be maxillary sinus. The 
radiologic methods were conventional sinus projections, 
hypocycloid  tomography (47) and computer tomography (28) 
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and orthopantomography(11).there were 3 cases which showed 
gingival tumors but found to arise from maxillay sinus. 
Trismus was evaluated in 1993 by Ichimura et al with tumours in 
head , neck areas. Out of two hundred twelve patients, twenty 
one cases demonstrated trismus were reviewed. 9 cases had 
trismus due to reflex muscle spasm or by infiltration of muscles 
of mastication. Five patients had trismus due to radiation. Seven 
cases had trismus due to surgical intervention. 
In 2009 oct 20 ,in journal laryngoscope, valerie j. lund, david j. 
howard, laura harding, william i . wei wrote an article on 
management options and survival in malignant melanoma in 
sinonasal mucosa. 
in september 1996, in journal radiographics, d m yousem, c li, k t 
montone, l montgomery, l a lovner,v rao,t s chung, y kimura,r e 
hayden and g s weinstein posted an article about primary 
malignant melanoma of the sinonasal cavity : mr imaging 
evaluation. 
In 1997, CT findings and diagnosis of maxillofacial tumours 
invading pterysopalatine fossa Wang P et al. Out of thirty three 
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cases who suffered from maxillofacial tumors affecting 
pterygopalatine space were retrospectively analysed. The 
important CT manifestations of this space was soft tissue mass 
occupancy and wall destruction. 
Kondo M, Ando Y in 1986 , studied squamous cell carcinomas 
of maxillary sinus regions sataged by CT scans.totally seventy 
two cases were taken and studied. 5, 31 and 36 tumors diagnosed 
as T2, T3, T4. Prognosis improved when maxillectomy was 
included as treatment protocol. Radiation therapy of sixty Gy or 
higher was found to be useful  in patients with T3 tumors. CT 
scans helped in classifying the tumours . the most important use 
of CT scnas were to identify the tumor extent precisely. 
In 2010, Kwon et al,Lyon et al,Floyd et al presented a  similar 
case of sinonasal adenoid cystic carcinoma presenting as a 
orbital mass. 
 A rare case of verrucous carcinoma of maxillary antrum was 
described by Ram B, Saleh HA in 1998. It is a type of carcinoma 
verrcuous type which is a squamous cell carcinoma well 
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differentiated. Very rare to occur in maxillary antrum. Totally 3 
cases were reported. 
In 2007 december, Ayotunde J Fasunla and Akeen O. Lasisi, 
conducted a study  and found out that most common histologic 
type among all malignant sinonasal neoplasm was squamous cell 
carcinoma (69%) similar results were obtained in our study. 
In 2006, Sideney Kadish, Max Goodman published an article 
about clinical analysis of 17 cases of olfactory neuroblastoma. 
In 1975, Byron J. Bailey, Stuart Barton, published an article 
stating the management and prognosis of olfactory 
neuroblastoma. 
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SURGICAL ANATOMY OF NOSE AND 
PARANASAL SINUS 
 
The nasal cavity is formed by structures from anterior to 
posterior as follows, 
1. Nasal Vestibule 
2. Nasal Septum 
3. Nasal Valve 
4. Lateral nasal Wall 
5. Choanae 
The lateral wall of nose is formed by, 
Bony Structure:  
1. nasal 
2. frontal 
3. ethmoid 
4. maxilla 
5. horizontal process of palatine 
6. superior concha (ethmoid) 
7. middle concha (ethmoid) 
8. inferior concha 
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9. sphenopalatine foramen 
10. medial pterygoid plate 
11. pterygoid hamulus of medial plate 
The roof of nasal cavity : 
1.Cribriform palate 
2.Ethmoid fovea 
The Floor of nasal cavity: 
Hard palate 
1.Maxilla (Ant) 
2.Palatine (Pos) 
Meatus of lateral wall: 
1. inferior meatus – largest 
 nasolacrimal duct opens here 
2. middle meatus 
 ethimoidal bulla  
 hiatus semilunaris 
 infundibulum 
 opening of frontal sinus 
 opening of maxillary sinus 
 opening of anterior ethimoidal cells 
 opening of middle ethimoidal cells 
3. superior recess 
 posterior  ethimoidal air cells  
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Blood supply : 
1. ARTERY (ANTERIOR ETHIMOIDAL ) 
2. ARTERY ( GREATER PALATINE)  
3. ARTERY ( SPHENOPALATINE) 
4. ARTERY ( SUPERIOR LABIAL ) 
 Venous   drainage : 
1. cavernous plexus beneath middle meatus. 
2. Sphenopalatine vein 
3. Facial vein 
4. Ophthalmic vein 
5. Superior sagittal sinus 
Nerve supply: 
1. Anterior ethimoidal nerve 
2. Posterior superior labial nerve 
3. Anterior superior alveolar nerve 
4. Anterior palatine nerve 
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NASAL SEPTUM 
The structures forming the nasal septum: 
 Columellar part: 
Medial crura of alar cartilages both sides 
 Membranous part 
 Quadrilateral cartilage 
 Bony part: 
1. Vomer 
2. Perpendicular plate of ethimoid 
3. Nasal spine of frontal bone 
4. Rostrum of sphenoid 
5. Nasal crest of palatine bone 
6. Nasal crest of maxilla 
Blood supply of nasal septum: 
1. Anterior ethimoidal artery 
2.  Artery of greater palatine 
3. Artery of sphenopalatine 
4. Artery of superior labial 
Venous drainage: 
1. Facial vein 
2. Sphenopalatine vein 
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Nerve supply: 
1. Internal nasal branch of anterior ethimoidal- 
ophthalmic nerve 
2. Nasopalatine branch of pterygopalatine ganglion – 
maxillary nerve 
3. Olfactory nerves 
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    Maxilla anatomy 
 
Osteology  
 
The maxillary sinus  is made of a pyramidal chamber with 
volume of 15 ml. Ostieum of maxillary sinus measures 3 to 4 
mm diameter. Uncinate process partially covers the medial 
aspect. The apex extends to zygomatic process of maxillary 
bone. Bony orbital floor forms the roof. Through the 
infraorbital canal the corresponding nerve runs in the orbital 
floor from posterior to anterior direction. 
 
Maxillary sinus floor is made of palatine process and alveolar 
process of maxilla and it is at a level of 1 to 1.2cm below the 
nasal cavity.Infraorbital foramen located in the mid superior 
portion of the anterior wall of maxillary sinus. Just above the 
canine tooth the canine fossa is present which is the thinnest 
portion. The anterior border of pterygopalatine fossa forms the 
posterior wall of the sinus, which contains the internal 
maxillary artery, sphenopalatine ganglion, second branch of 
trigeminal nerve, vidian nerve ,  greater palatine nerve. 
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Embryology : 
The first sinus to develop is maxillary sinus. On or about 70th 
day of gestation .  after each nasal fossa and its turbinates are 
formed , from inferior to superior turbinate a small ridge 
develops & medially projects into maxilla. A mucosal bud 
slowly develops just superior and posterior to this ridge which 
slowly borrows laterally into maxilla. In the central part the 
evagination is located which  is called the infundibulum. The 
evagination expands to produce a cavity measuring 7 x 4 x 4 
mm. After birth  the facial structures starts to grow away from 
skull anteroinferiorly from the skull. At the age of 12 years the 
floor of the sinus has expanded that it lies on the horizontal 
level with the floor of the nasal chamber. 
 
The  development of teeth is closely related to the expansion 
the maxillary sinus. When the tooth erupts, the space 
vacatedby it forms the sinus lumen. This process of expansion 
stops after permanent erupts. The  adult size of maxillary sinus 
was determined by Schaffer after analyzing   150 skull bones 
and found out that the dimension were : 23 mm wide ,  34 mm 
anteroposteriorly , 33 mm high and a volume of 14.75 ml. 
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S.No   Walls Relations 
1 
MEDIAL 
WALL 
Natural And Accessory Ostium. Seperates Nasal Cavity 
From Maxillary Sinus 
2 
Anterior 
Wall Cheek 
3 Roof. 
Infraorbital  Vessels & Nerves. Seperates From Orbital 
Cavity 
4 Floor 
Related To Palatine Process Of Maxilla Molar Teeth In 
Alveolar Process 
5 
Posterior 
Wall  Related To Pterygopalatine Fossa & Infratemporal Fossa 
S.NO                                         ARTICULATIONS 
1  NASAL BONE 
2 MAXILLARY PROCESS OF FRONTAL BONE 
3 PTERYGOID PLATES OF SPHENOID BONES 
4 INFERIOR NASAL CONCHA 
5 
PYRAMIDAL PROCESS AND HORIZONTAL PROCESS 
OF PALATINE BONE 
6 MAXILLARY PROCESS OF ZYGOMA 
7 MAXILLA OF OPPOSITE BONE 
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The above tabular column details the articulations of the maxilla 
bone in all sides. 
Processes : 
1. Frontal 
2. Alveolar 
3. Palatine 
4. Zygomatic  
Surfaces: 
1. Nasal surface ( medial) 
2. Orbital surface ( superior ) 
3. Inferotemporal surface  
( posterolateral ) 
4. Facial surface ( anterolateral) 
Lymphatics: 
a. Superficial and deep longitudinal lymphatic 
capillary network related to maxillary sinus 
ostium. 
b. Lymphatic connections over pterygopalatine 
plexus to the Eustachian tube and the 
nasopharynx. 
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        At the above said area the lymphatics directly connects to 
the nasal vessels and finally enters the nasopharyngeal area. 
The primary lymphatic chains are the retropharyngeal and lateral 
cervical lymph nodes. 
Innervation : 
 Most of the sensation of maxillary snius are from the 
posterior superior alveolar nerve. The anterior portion of 
maxillary sinus is supplied by the anterior superior alveolar 
nerve. The secondary mucosal innervations is by the middle 
superior alveolar nerve. 
Blood supply : 
a. Greater palatine artery 
b. Maxillary artery 
c. Facial artery 
d. Infraorbital artery 
Venous drainage : 
a. Pterygoid plexus 
b. Anterior facial vein 
Histology: 
It is lined by the ciliated columnar epithelium which contains a 
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rich supply of goblet cells. 
 
PTERYGOPALATINE FOSSA 
It forms the pathway of spread of malignancy from the head and 
neck tumours to the base of skull. 
It is bounded by base of the sphenoid bone and pterygoid plates 
posteriorly and superiorly by palatine bone and anteriorly by 
maxillary bone. 
Horizontal plate of palatine bone fuse with posteriori third of 
hard palate that in turn fuses with the palatine processes of 
maxillary bones to form a complete hard palate. 
Posterior surface of medial wall of maxillary bone fuses 
anteriorly with perpendicular plate. 
There is  fissure that connects the the fossa with space where the 
masticatory muscles are found. 
The fossa has : 
Anterior  occupied by 3rd part  of maxillary artery 
Posterior by ganglion ( sphenopalatine) and nerve (maxillary). 
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Relations : 
a. Anteriorly : through the inferior orbital fissure to the orbit 
b. Medially : through the sphenopalatine foramane to the 
posterior nasal fossa 
c. Laterally : through the pterygomaxillary fissure to the 
masticator space 
d. Inferiorly : through thelesser and greater palatine foramina 
to the palate. 
e. Posterioly and superiorly : through the foramen rotundum 
to the meckel cave and cavernous sinus. 
f. Posterioly and inferiorly : through the vidian canal to the 
middle cranial fossa 
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ETHIMOID SINUS 
It develops in 3rd fetal month. It forms as anterior as evaginations 
in middle meatus and posterior cells in superior meatus. 
At birth 3 – 4cells develops.it is evident on x ray until 1 ya. It 
reaches adult dimension by 12 ya. The dimension 20 x 20 x 10 
ml the volume is 15 ml.  
Keros classification : 
a. Type 1 : cribriform plate 1 – 3 mm below fovea 
ethimoidalis 
b. Type 2 : 4 – 7 mm below 
c. Type 3 : 8 – 16 mm below 
ome of ethimoid in horizontal plate : 
Area where anterior ethimoidal artery traverses 
ethimoid roof. It might cause orbital hematoma if 
injured. 
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Anterior cells : 
  Drain into ethimoid infundibulum of middle meatus 
-Frontal recess cells: 
-most anterior cells 
-0-4 cells 
-form frontal sinus, supraorbital air cells 
    S.No  Walls  Relations 
1 
LATERAL 
WALL Lamina Papyracea 
2 MIDLINE 
Vertical Plate Of Ethimoid Bone , Superior Portin Crista 
Galli , Perpendicular Plate Of Ethimoid Bone As Inferior 
Portion 
3 
MEDIAL 
WALL Lateral Wall Of Nose 
4 ROOF 
THIN MEDIAL : Cribriform Plate , 
 THICK LATERAL : Fovea Ethimoidalis , Lateral Lamella 
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-Infundibular  cells: 
-next most anterior 
-1-7 cells 
agger nasi   
cells extend outside ethmoid capsule 
-represent superior remnant of the first 
ethmoturbinal 
-in close proximity to frontal recess 
-often opened during FESS    
-consistent location in middle meatusF.Ling - Sinus Anatomy 
and Function  
-form bulla ethmoidalis 
-may form suprabullar recess if anterosuperior wall of bulla does 
not reach ethmoid roof 
-uncinate process: 
-thin semilunar piece of bone; part of ethmoid bone 
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-remnant of first ethmoturbinal 
-middle turbinate: 
-concha bullosa: 
-pneumatization of middle turbinate; in 12% of population 
-may result in nasal obstruction 
-anterior end attaches to horizontal plate 
-posterior end inserts laterally on lamina papyracea 
-vasculature: 
-anterior and posterior ethmoid arteries 
-maxillary and ethmoid veins (cavernous sinus) 
-innervation: 
-anterior and posterior ethmoidal nerves (from nasociliary nerve, V1) 
Frontal Sinus 
-develops from anterosuperior ethmoidal cells 
-frontal recess: 
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--anterior wall: agger nasi cells 
-lateral wall: lamina papyracea 
-posterior wall: anterior face of bulla ethmoidalis 
-medial wall: middle turbinate, uncinate process 
Drainage pattern: 
-A: UP  LP (80%); drainage medial to uncinate 
process to middle meatus 
-B: UP  base of skull; drainage lateral to uncinate 
process to infundibulum 
-C: UP  middle turbinate; drainage lateral to 
uncinate process to infundibulum  
vasculature: 
-supraorbital and supratrochlear arteries 
-ophthalmic (cavernous sinus) and supraorbital 
(anterior facial) veins 
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-innervation: 
-supraorbital and supratrochlear nerves (V1) 
-structure of sinus variable 
-anterior wall is strongest, twice as thick as 
posterior wall 
-drainage ostium in posteromedial portion of sinus 
floor 
Foramina of Breschet: small venules that drain the sinus mucosa 
into the dural veins  
Sphenoidal Sinus 
-anatomical relationships of sphenoid ostium: 
-face of sphenoid sinus lies 7 cm from nasal sill at 30 DEGREE 
angle with floor of nasal cavity 
-empties into sphenoethmoidal recess via small ostium 
-adjacent to the nasal septum near the posterior border. 
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-0.5-4 mm in diameter 
-located 10-15 mm above sinus floor or 30 degree above floor of 
nasal cavity 
-1/3 up from choana to base of skull 
-cavernous sinus external and lateral to sinus 
-bony tubercle surrounding optic nerve dehiscent in 4% of 
population 
-dehiscent internal carotid artery in 7% 
-maxillary branch of trigeminal nerve and vidian nerve produce 
bulges in sphenoidal sinus in 30%. 
-vasculature: 
-sphenopalatine artery  
-maxillary vein (pterygoid plexus) 
-innervation: 
-sphenopalatine nerve (parasympathetic fibers and V2) 
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Lymphatic Drainage of the nose and sinuses 
-anterior 1/3 of nose : 
 submandibular nodes 
-posterior 2/3 of nose and sinuses : 
retropharyngeal nodes (Rouviere) and superior deep cervical nodes 
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INFRATEMPORAL FOSSA 
 
Boundaries : 
a. Inferior : in continuity with parapharyngeal space 
b. Medial : lateral pterygoid plate 
c. Anterior : posterior wall of maxilla 
d. Lateral : zygomatic arch ,  masseter, temporalis, medial 
surface of ramus of mandible , upper most part of the deep 
lobe of parotid. 
e. Posterior : styloid apparatus , carotid sheath , prevertbral 
fascia. 
f. Roof : infra temporal surface of grater wing of sphenoid 
and by small portion of squamous part of temporal bone. 
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Contents : 
a. Vessels : pterygoid plexus of veins , maxillary artery and 
vein. 
b. Muscles : muscles of mastication – medial & lateral 
pterygoid , temporalis , masseter. 
c. Nerves : mandibular nerve and otic ganglion. 
d. Chorda tympani nerve 
e. Temporomandibular joint. 
 
The surgical importance of infratemporal fossa pertaining to our 
study is that the involvement of this fossa by sinonasal tumours 
is highly difficult to operate. It can be considered a relarive 
contraindications as far as sugery is considered in our setup. 
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PTERYGOID PLEXUS OF VEINS 
Site: 
 Around the lateral pterygoid muscle. 
Tributaries: 
a. Veins with branches of maxillary artery 
Maxillary vein unite with superficial temporal vein to form the 
retromandibular vein. 
 
Communications : 
a. Inferior orbital vein through inferior orbital fissure 
b. Cavernous sinus through emissary vein 
c. Facial vein through deep facial vein 
 
 
 
 
 
 
. 
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Otic ganglion 
It is a peripheral parasympathetic ganglion that supplies 
secrtomotor fibres to parotid gland. 
Topography : 
 Connected with mandibular nerve. 
Functionally to glossopharyngeal nerve. 
Site : 
2 -3 mm in size and found in the infratemporal fossa below the 
foramen ovale between mandibular nerve and tensor veli 
palatine muscle. 
Branches and communications : 
a. Sympathetic        
   nerve fibres from plexus on middle 
meningeal artery. They are post ganglionic fibres from 
superficial sympathetic ganglion. Travel to otic ganglion 
to auriculotemporal nerve to parotid gland. 
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b.  Parasympathetic :  
Through lesser petrosal nerve. 
They are pre ganglionic fibres fro inferior salivatory 
nucleus to ninth nerve to tympanic branch to 
tympanic plexus to lesser petrosal nerve to otic 
ganglion 
The post ganglionic fibres from otic ganglion 
through auriculotemporal nerve to parotid gland. 
c. Sensory :        
 from parotid gland through auricultemporal nerve. 
d. Other connections:       
   1. Branch from nerve to medial 
pterygoid which passes as such through otic ganglion to 
supply tensor veli palatine and tensor tympani. 
1. Chorda tympani which is 
connected otic ganglion. This 
provides an alternate pathway 
of taste to anterior 2/3 of 
tongue. 
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SPHENOPALATINE FORAMEN 
The foramen is situated above the perpendicular plate of palatine 
bone area. It is the entry point for neuro vascular structures those 
that communicate between pterygopalatine fossa and the nasal 
cavity. 
The structures running through the foraman are : 
1. Lateral posterior superioir nasal nerves supplying 
lateral wall of nose . 
2. Nasopalatine nerve that continues through the incisive 
canal to innervate the anterior aspect of hard palate. 
3. Medial posterior superior nasal nerves innervating the 
nasal septum. 
4. Sphenopaltine artery , a branch of maxillary artery 
5. Veins accompanying the sphenopalatine artery. 
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CLASSIFICATION OF NASAL AND PARANASAL SINUS 
TUMOURS 
 
Benign Malignant 
A) Epithelial   
1. Adenoma 1. Squamous cell carcinoma 
2. Papilloma 2. Adeno carcinoma 
  3. Anaplastic carcinoma 
  4. Transitional cell carcinoma 
  5. Malignant melanoma 
  6. Salivary gland tumours 
   a) Adenoid cystic carcinoma 
   b)Mucoepidermoid carcinoma 
   c) Malignant pleomorphic adenoma 
  7. Aesthesioneuroblastoma 
B) Non - Epithelial   
1. Fibroma 1. Fibrosarcoma 
2. Hemangioma 2. Angiosarcorna 
3. Nasal glioma 3. Hemangiopericytoma 
4. Neurilemmoma 4. Malignant lymphoma 
5. Chondroma 5. Rhabdomyos arcoma 
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6. Osteoma 6. Lymphosarcoma 
7. Meningioma 7. Plasmacytoma 
  8. Burkitts lymphoma 
FIBRO - OSSEOUS TUMOURS   
Benign Malignant 
Osteoma Osteosarcoma 
Ossifying fibroma Ewing’s sarcoma 
Osteoblastoma   
Osteoid osteoma   
Chondroma Chondrosarcoma 
Chondroblastoma   
Chondromyxoid fibroma Fibrosarcoma 
Desmoplastic fibroma 
Malignant fibrous histiocytoma 
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ODONTOGENIC TUMOURS 
  
EPITHELIAL 
 
1. Ameloblastoma  
 
2. Adenomatoid odontogenic tumour  
 
3. Calcifying epithelial odontogenic tumour  
 
4. Ameloblastic fibroma  
 
5. Ameloblastic fibrosarcorna  
 
6. Odontoma
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MESODERMAL 
 
1. Myxoma  
 
2. Odontogenic fibroma  
 
3. Cementoma  
 
a) Benign cementoblastoma  
 
b) Cementifying fibroma  
 
c) Cemento ossifying fibroma  
 
d) Familial gigantiform cementomas  
 
METASTATIC TUMOURS  
MISCELLANEOUS TUMOURS  
2. Melanotic neuro ectodermal tumour
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STAGING OF SINONASAL TUMOURS 
 
MUCOSAL SINONASAL TRACT AND NASOPHARYNX 
MALIGNANT MELANOMA – STAGING. 
T1 : lesion limited to one anatomis site 
T2 : lesion limited to 2 or more anatomis site 
Nodal staging 
N1 : any lymph node involvement 
Distant metastases 
M1 : distant  metastases. 
INVERTED PAPILLOMA 
Krouse classification: 
T1 – lesion  limited to the nasal cavity only. 
T2 –lesion confined to superior & medial part of maxillary sinus , 
ethimois sinus. 
T3 –  lesion extending to inferior / lateral part of maxilla or frontal or 
sphenoid sinus 
T4 – lesion extend outside nose & sinuses. It might be malignancy also 
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ESTHESIONEUROBLASTOMA 
Kadish staging system 
 
Lesion is limited to cavity of nose --- stage A 
Lesion limited to 1 or several of siniuses and the cavity of nose ---   stage B 
Lesion encroaching beyond cavity of nose entering in to skul base , nodes in 
cervical region , orbital area, metastases to distant areas.  --- stage C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
STAGING OF MAXILLARY SINUS CARCINOMA 
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1.  Sebileau classification (1906) 
 
Draw two parallel lines    1. Through floors of the orbits 
   2. Through floors of the maxillary antrum 
 
Divides into   
1. Supra structure : Ethmoid, sphenoid, frontal sinus and 
   olfactory portion of nose 
2. Mesostructure : Maxillary sinus and respiratory 
   portion of nose. 
3. Infrastructure : Alveolar process 
 
2. Ohngren’s classification (1933) 
One line passing from inner canthus of the eye to the angle of the 
mandible and another line passing through mid pupillary region. 
It divides maxillary sinus into four quadrants. 
1.antero infero medial 
2.anteroinfero lateral 
3.posterosuperolateral 
4.posteosuperomedial 
It stated that all sinonasal tumours involving the suprstructural portions 
according to Ohngren’s have a poor prognosis. But all sinonasal tumours 
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involving infrastructural portions according to Ohngren’s classification have 
a good prognosis. 
 
3. Modified Sisson classification (1963) 
T1 : Invasion of anterior wall (or) Inferior nasoantral wall (or) Anterior 
medial wall --- no skin involvement. 
T2 : Invasion of lateral wall without muscle involvement 
  Invasion of superior wall without orbital involvement 
T3 : Invasion of pterygoids (or) orbit (or) anterior ethmoid cells 
  (or) anterior wall without involvement of cheek. 
T4 : 
Invasion of cribriform plate (or) pterygomaxillary 
fossa 
  (or) nasal fossa (or) other sinuses (or) pterygoid plate 
  erosion. 
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Lederman classification [1969] 
 
Tumor confined to 1 sinus or areas like vestibule , septum , turbinate --- T1 
 
Tumour involving the horizontal extent of the above said area or 2 nearby 
related vertically --- T2 
 
Tumour  extending to the above said areas along with invoving the orbit --- 
T3 
 
Tumour encroaching the nasopharygeal area , upper jaw , oral cavity , 
pterygopalatine fossa – T4.  
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4. Harrison classification (1978) 
 
 
 
 : 
T1 --  Limited to antral mucosa without evidence of erosion 
of 
  
bone. 
 
 
 : 
T2 -- Bone erosion but without involvement of the facial 
skin, 
  
 orbit, ethmoid (or) pterygopalatine fossa. 
 
 
 
   : 
T3 -- Lesion encroaching the skin of the face ,   ethimoid 
area , orbital area. 
   
    T4 – Lesion encroaching the pterygopalatine fossa , 
sinus of sphenoid , nasopharyngeal area , lamina cribrosa. 
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6. American Joint Committee on Cancer (AJCC) Classification 
 
    T ( PRIMARY TUMOUR) 
 
 To : PRIMARY TUMOUR no evidence 
 
 T1 : limited to mucosa of antrum of infrastructure but no erosion of 
bone or destruction. 
 T2 : limited to mucosa of antrum suprastructure or mucosa of antrum 
infrastructure with inferior or medial bony wall only. 
 T3 : extending more by invading the orbit , pterygoid muscle , cheek , 
ethimoid 
 T4 :more extensive than T3 by extending to sphenoid , plate of 
cribriform , skull base , cranial nerves , posterior ethimoid. 
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Nasal cavity & ethmoid sinus 
 ( PRIMARY TUMOUR) 
T1 : lesion limited to 1 subsite , with or no bone invasion. 
T2 : lesion extending to two subsites in single area or involvement of adjacent 
areas with or no bone invasion. ( within the area of nasoethmoidal complex) 
T3 :  lesion invading the floor of orbit or medial wall of orbit , lamina cribrosa 
or maxilla or palate. 
T4a : lesion extending to 1 of areas like ; 
 Cheek skin , nose skin, anterior aspect of orbit , cranial fossa of anterior part , 
frontal sinus, pterygoid plate , sphenoid sinus. 
T4b : lesion extend to 1 of areas like : 
      Brain , apex of orbit , nasopharynx , cranial fossa of middle part , dura , 
clvus , cranial nerve except V2. 
  
7. International union for cancer control (UICC – 2002) 
Lesion confined to mucosa of  maxillary sinus without any evidence of 
bony destruction  -- T1 
Lesion confined to hard palate, middle meatal area without involving 
maxillary posterior wall , orbit medial wall , floor , ethimoids , fossa of 
pterygoid , subcutaneous tissue with evidence of  bony destruction  – T2 
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Lesion involving  orbit medial wall , fossa of pterygoid , orbit floor , 
maxillary posterior wall , subcutaneous tissue – T3 
Lesion encroaching  nose skin , content of orbit ( anterior) , cheek skin , 
cranial fossa ( anterior ) , sinuses like frontal and sphenoid , pterygoid 
plate – T4a. 
      Lesion encroaching the brain , cranial nerves except                    
maxillary division of trigeminal nerve, apex of orbit, clival area , 
nasopharygeal area – T4b 
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STAGING OF NECK NODES 
 
There is no lymph node metastases – N0 
Involvement of one same side node less than or equal to 3 centimeter -
-    N1 
Involvement of same side one node more than three centimeter and  
less than six centimeter – N2a 
Involvement of  same side several nodes not more than six centimeter 
– N2b 
Involvement of opposite or both side nodes not more than six 
centimeter  – N2c 
Involvement of nodes more than six centimeters – N3. 
 
METASTASES TO DISTANT AREAS 
 
Metastases to distant areas cant be evaluated – MX 
No metastases to distant areas – M0 
Involvement of metastases to distant areas – M1 
TNM Staging for SINONASAL TUMOURS 
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Stage Grouping 
Stage 0                      Tis N0 M0 
Stage I                       T1 N0 M0 
Stage II                      T2 N0 M0 
Stage III           T3 N0 M0 
                                    T1 N1 M0 
                                    T2 N1 M0 
                                    T3 N1 M0 
Stage IVA                  T4a N0 M0 
                                    T4a N1 M0 
                                    T1 N2 M0 
                                    T2 N2 M0 
                                    T3 N2 M0 
                                    T4a N2 M0 
Stage IVB                   T4b Any N M0 
                                     Any T N3 M0 
Stage IVC                    Any T Amy N M1 
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Clinical Stage Grouping by T and N Status 
                    T1    T2      T3      T4a       T4b 
N0               I      II        III      Iva           IVb 
N1              III   III       III      IVa         IVb 
N2              Iva   IVa     IVa    IVa       IVb 
N3              IVb  IVb     IVb    IVb      IVb 
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MATERIALS AND METHODS 
 
The study was done in  Government Rajaji Hospital,Madurai medical 
college, Madurai, from October 2010 to October 2012. 
 
Out of the patients who attended the outpatient department during the 
period, those with symptoms and signs suggestive of  sinonasal masses were 
screened further. 
After thorough clinical examination, the patients were subjected to 
Endoscopy into the nasal cavity and computed tomography scan for the 
sinonasal area were performed. 
 
Those with histologically confirmed benign and malignant tumors were 
selected for the study. 
 
The total number of 50 patients were selected for the study and their  
surgical and non surgical outcomes were noted. 
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Based on the clinical profile of the patient and and the clinical status of the 
cases the correct management profile was designed and the management was 
carried accordingly. 
The  treatment consisted of surgery followed by radiotherapy or 
chemoradiation. 
The surgery performed was total maxillectomy. 
 
Patient was under regular follow up at intervals of first 6 months and once in 
3 months of the next 1 year. 
 
The clinical examination and findings were done in the following  order 
uniformly: 
1) Examination of nasal cavity and noting of any intranasal mass (or) medial 
displacement of lateral nasal well. 
2) Examination of oral cavity, which includes, inspection and palpation of 
hard palate, maxillary teeth, alveolar and gingivobuccal sulcus. 
3) Visualization of nasopharynx and choana 
4) Examination of the cheek for the presence of mass, inflammation (or) 
involvement of infraorbital nerve. 
5) Assessment of visual acuity, extra – ocular movements and displacement 
of the globe. 
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6) Examination of the ear for otitis media with effusion  
7) Performing a cranial nerve examination 
8) Examination of neck for regional lymph nodes.  
 
 
Imaging 
 
CT scan paranasal sinuses were done in all 50 patients (coronal and axial 
view, plain and contrast) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
69 
 
 
 
 
 
 
 
AGE INCIDENCE 
 
 
Patients belonging to the fifth decade of life had maximum incidence – 40% 
 
AGE No. of patients Percentage 
0 - 10 0 0 
11 -- 20 0 0 
21 -- 30 2 4% 
31 -- 40 7 14% 
41 -- 50 10 20% 
51 -- 60 20 40% 
61 -- 70 10 20% 
71 -- 80 1 2% 
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AGE INCIDENCE 
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SEX   INCIDENCE 
 
 
SEX 
 
No. of patients 
 
Percentage 
 
Male 
 
45 
 
90% 
 
Female 
 
5 
 
10% 
 
Most of the patients were males more ¾ of the total number of patients. 
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SEX INCIDENCE 
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CLASSIFICATION AND  STAGING 
 
TNM STAGING No of patients Percentage 
T1 2 4.5% 
T2 10 22.7% 
T3 19 43.2% 
T4 13 29.5% 
N0 24 54.5% 
N1 16 36.4% 
N2 4 9.1% 
N3 0 0 
We classified all patients using UICC classification.Majority of the lesions 
were T3.None of the patients had distant metastases 
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T STAGING 
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N STAGING 
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BRODER’S STAGING 
 
GRADE No. of patients Percentage 
I(Well differentiated) 11 36.6% 
II( Moderately differentiated) 10 33.3% 
III(Poorly differentiated) 6 20% 
IV(Undifferentiated) 3 10% 
 
 
Most of the patients were under  GRADE  I  ((Well differentiated) 
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BRODER’S STAGING 
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DISCUSSION 
Sinonasal malignancies, a highly heterogeneous group of cancers, account 
for less than 1% of all cancers and less than 3% of all upper aerodigestive 
tract tumors 
 
A. AGE  INCIDENCE: 
Majority of patients belonged to the fifth decade(40%) of life. This 
co-incides with the age incidence reported in literatures. 
 
B. SEX  INCIDENCE: 
In our study,out of 50 patients, 45 were males and 5 were 
females.Thus it denotes  90%  of cases were males.This coincides 
with the fact that incidence of sinonasal tumours are more common in 
males than females. 
C. TNM STAGING 
TNM staging system is a useful parameter on which treatment 
protocol can be based. It also helps to compare the results and 
standardize disease states. In our study majority of patients were 
under tumor staging T3(43.18%)  
The remaining cases were T4(29.5%) and T2(22.7%). 
Majority of patients were belonging to nodal status N0(54.5%). 
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Rest were belonging to N1(36.4%),N2(9.1%) ,N3 (0).  
 
D. BRODER STAGING : 
In our study, all the fifty patients were subjected to biopsy and 
specimen was sent to histopathology. All the reports were given as 
per broder’s classification. 
     The results were ; 
a. Most common grade of squamous tumour was   
GRADE I (36.6%) 
b. Other grades were as follows : 
GRADE II : 33.3% 
GRADE III : 20 % 
GRADE IV : 10 % 
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CONCLUSION 
The work up , management and follow up of sinonasal tumours is 
complicated by the multiple potential sites and stages of development. 
Various array of options of management of tumours are radical surgery 
alone, surgery followed by radiotherapy , chemoradiotherapy and 
stereotactic gamma knife surgery. 
This  study was performed because of the high incidence of the sinonasal 
tumours in Government Rajaji Hospital , Madurai. 
Combined modality approach was entitled for the patients under study which 
included otolaryngologist , radiotherapist , neurosurgeon , medical 
oncologist , surgical oncologist , psychiatrist , psychologist , radiologist , 
pathologist , dentist , nutritionist ,  social worker. 
This approach had an advantage of earlier diagnosis of the tumours , 
accurate delineation of the tumour , precise and appropriate treatment. All 
these factors improved the prognosis and thus extended the survival rate of 
the patients. 
The role of surgery followed by radiotherapy played a pivotal role in the 
stage I and stage II tumours where a complete cure was almost possible. 
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The role of radiotherapy in stage III and stage IV played a good palliative 
role in inoperable cases. 
Complete tumour removal was very much possible both through open and 
endoscopic methods. 
The role of chemotherapy combine with radiotherapy was efficient in 
preventing recurrence and residual tumour rates. Induction chemotherapy 
followed by maintenance therapy reduced the side effects of 
chemotherapeutic agents, 
The goals of treatment can be attained by multidisplinary and multi modality 
approach.   
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 PROFORMA 
A CLINICOPATHOLOGICAL STUDY AND TREATMENT OF  MASSES IN  
SINONASAL CAVITY 
 
Name of the patient :                                        age :       Sex : 
S.No : 
Place of residence :                                          Occupation : 
Socioeconomic Status :                                    Hospital Number : 
HISTORY 
A) COMPLAINTS DURATION 
1) 
2) 
3) 
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H/O Present Illness 
NOSE: SYMPTOMS DURATION 
I) Nasal obstruction R/L/B 
II) Nasal Discharge R/L/B 
III) Headache 
IV) Facial pain Unilateral / Bilateral 
V) Nasal Bleeding R/L/B 
VI) Change of voice 
VII) Smell disturbances Hyposmia / Anosmia 
VIII) Nose deformity 
EYE 
I) Proptosis 
II) Pain 
III) Watery Eyes 
IV) Blurring of vision 
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V) Diplopia 
ORAL CAVITY 
I) Pain 
II) Palatal ulcer 
III) Mouth ulcer 
CRANIALNERVES: 
I) Anosmia 
II) Loss of vision 
III) Diplopia 
IV) Ophthalmoplegia 
V) Trigeminal Anaesthesia 
VI) Facial palsy 
VII) Nasal regurgitation 
MISCELLANEOUS: H/O Loss of Weight & Appetite 
PAST HISTORY: 
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1. Previous treatment 
a) Drugs - Steriod therapy - Duration 
b) Surgery - Endoscopic / External approach / Combined 
2. H/o Immuno suppression 
3. H/o Diabetes / Hypertension / IHD 
PERSONAL HISTORY: 
Smoking / Alcoholic / Snuff / Gardening 
FAMILY HISTORY : 
OCCUPATIONAL HISTORY : 
1) GENERAL EXAMINATION : 
Build : 
Nourishment : 
Anaemia : 
Weight / BP / Temperature : 
SYSTEMIC EXAMINATION 
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Cardiovascular system : Heart sounds / Murmur 
Respiratory System : 
Abdomen : 
Central Nervous System : 
LOCAL EXAMINATION 
1. NOSE : Skin 
External Contour 
Nasolabial fold 
Anterior Rhinoscopy : 
Septum Deviated to R/L/Midline - 
Mass - 
Probing - 
Nasal Airway - 
Bleeding on touch - 
Nasal discharge - 
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Posterior Rhinoscopy : 
Mass 
Discharge 
Choanae / Eustachian Tube 
2. ORBIT : 
Proptosis 
Acuity of vision 
Movement of the eye ball 
Lacrimation 
Oedema of the eyes 
Hypertelorism 
3. ORAL CAVITY : 
Oral mucosa 
Teeth 
Hard & Soft palatal ulcer 
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4. EXAMINATION OF CRANIAL NERVES : 
5. EAR : 
6. THROAT : 
Indirect Laryngoscopic Examination 
INVESTIGATIONS 
Routine blood and urine tests 
Blood sugar / urea / Lipid profile 
Radiological Investigations 
X-ray or Paranasal sinuses 
& Nasopharynx 
CT Scan of Nose and Sinuses 
MRI 
Nasal Endoscopy Findings 
 
PROVISIONAL DIAGNOSIS: 
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NONOPERATIVE TREATMENT 
  
OPERATIVE TREATMENT: 
Endoscopic sinus surgery 
 
PER-OPERATIVE FINDINGS 
 
POST-OPERATIVE COMPLICATIONS 
 
HISTOPATHOLOGICAL REPORT 
 
FINAL DIAGNOSIS 
 
POST- OPERATIVE TREATMENT AND FOLLOW UP 
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PATIENT 1 
 
    
 
 
PATIENT 1 (CONTD.) 
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PATIENT 2 
 
  
 
 
 
PATIENT 2(CONTD.) 
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PATIENT 3 
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PATIENT 4 
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PATIENT 5 
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PATIENT 6 
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PATIENT 7 
 
 
 
 
PATIENT 8 
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PATIENT 9 
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MASTER CHART 
 
Sno NAME AGE & SEX IP NO SYMPTOMS HISTOPATHOLOGY STAGING TREATMENT  
1 MURUGESAN 70/M 23761 
Left nasal 
obstruction,anosmia 
Adeno-squamous cell 
carcinoma. T4NOMx Radiotherapy 
2 Shenbagamoorthy 56/M 64213 
Left nasal 
obstruction,anosmia 
Adenoid cystic 
carcinoma T3NOMx 
Lateral 
Rhinotomy,medial 
maxillectomy,Post 
op radiation 
3 Manoharan 65/M 80638 
B/L nasal 
discharge,epistaxis 
well differentiated 
squamous cell 
carcinoma T3NOMx Chemo-Radiation 
4 Mohan 51/M 21094 
B/L nasal 
obstruction,epistaxis 
well differentiated 
adenocarcinoma T4NOMx Chemo-Radiation 
5 Loothusamy 71/M 62037 
B/L nasal 
obstruction,blurring 
of vision ossifying fibroma  
Lateral 
Rhinotomy,medial 
maxillectomy 
6 Ravichandran 55/M 62945 
Right side facial 
pain,epistaxis 
Poorly differentiated 
squamous cell 
carcinoma T3N1M0 Chemo-Radiation 
7 Chinnammal 70/F 60946 
Frontal 
headache,epistaxis 
moderately 
differentiated squamous 
cell carcinoma T3N2M0 Chemo-Radiation 
8 Nallaiya 55/M 60649 
Swelling inside 
mouth,loosening of 
teeth 
well differentiated 
squamous cell 
carcinoma T3N1M0 Radiotherapy 
9 Sundarammal 60/F 47711 
Swelling in right 
side face 
Poorly differentiated 
squamous cell 
carcinoma T4NOMx Chemo-Radiation 
10 Kannan 42/M 65137 
B/L nasal 
obstruction 
Squamous cell 
carcinoma grade II T3NOMx Chemo-Radiation 
11 Arockiam 70/M 58181 Epistaxis 
Squamous cell 
carcinoma grade II T4NOMx Radiotherapy 
12 Kumaraiya 67/M 64959 
B/L nasal 
discharge,epistaxis 
Undifferentiated non-
keratinising carcinoma  T2NOMX  
13 Thangamalai 47/M 48391 
B/L nasal 
obstruction,epistaxis 
Squamous cell 
carcinoma grade I T3N1M0 Chemo-Radiation 
14 Amala 40/M 55770 
right side nasal 
obstruction 
Squamous cell 
carcinoma grade II T2N1MO Chemo-Radiation 
15 Chellammal 50/M 55167 
Left nasal 
obstruction,anosmia 
Squamous cell 
carcinoma grade I T3NOMx Chemo-Radiation 
16 Seenivasan 60/M 53508 B/L epistaxis 
Squamous cell 
carcinoma grade II T4NOMx Chemo-Radiation 
17 Kaniyammal 50/M 26478 
B/L nasal 
obstruction Adenocarcinoma T2N1MO Chemo-Radiation 
18 Samidoss 60/m 51121 
B/L nasal 
discharge,epistaxis 
Well differentiated 
squamous cell 
carcinoma T4N1MX Chemo-Radiation 
19 Lakshmi 62/M 99141 
B/L nasal 
obstruction,epistaxis 
moderately 
differentiated squamous 
cell carcinoma T3N1M0 Chemo-Radiation 
20 Natarajan 59/M 41712 
B/L nasal 
obstruction 
Non-keratinising 
carcinoma T4N1MX Chemo-Radiation 
21 Karuppasamy 60/M 27960 Right side epistaxis 
Invasive squamous cell 
carcinoma T4N1MX Chemo-Radiation 
22 Nallakannan 58/M 32996 
Left nasal 
obstruction,anosmia 
Squamous cell 
carcinoma grade I T2NOMX Chemo-Radiation 
23 Sangaiah 65/M 29795 Right side epistaxis 
Squamous cell 
carcinoma grade III T3N1Mx Radiotherapy 
24 Karupiah 55/M 23664 
Right sided 
headache 
Well differentiated 
squamous cell 
carcinoma T3N0Mx Chemo-Radiation 
25 Manikandan 32/M 23108 
Left nasal 
obstruction,anosmia Squamous papilloma T3N1M0 Chemo-Radiation 
26 Gurusamy 70/M 19370 
B/L nasal 
obstruction 
Squamous cell 
carcinoma grade II T2N1MO Chemo-Radiation 
27 Kuppan 55/M 12919 
B/L nasal 
obstruction 
moderately 
differentiated squamous 
cell carcinoma T3N2M0 Chemo-Radiation 
28 Arockiasamy 70/M 31137 Right sided epistaxis 
Squamous cell 
carcinoma grade II T4N1MX Chemo-Radiation 
29 Thanikodi 65/M 11315 
Left nasal 
obstruction,anosmia Malignant melanoma T3N0Mx Lateral Rhinotomy 
30 Muthiah 51/M 54543 
Right nasal 
obstruction 
Squamous cell 
carcinoma GRADE III T4N0MX Chemo-Radiation 
31 Arumugam 32/M 46241 
Left nasal 
obstruction,Epistaxis 
Poorly differentiated 
squamous cell 
carcinoma T4NOMx Chemo-Radiation 
32 Pathrakali 40/F 65732 
Right nasal 
obstruction 
well differentiated 
squamous cell 
carcinoma T3N1Mx Chemo-Radiation 
33 Ponnusamy 52/M 40550 Right nasal epistaxis 
moderately 
differentiated squamous 
cell carcinoma T3N1M0 Chemo-Radiation 
34 Manikandan 30/M 45502 Left nasal discharge 
Adenocarcinoma 
(Intestinal type) T3NOMx  
35 Veeramalai 57/M 60387 Right nasal epistaxis 
Metastatic 
carcinomatous deposits ? Radiothrapy  
36 Sekar 32/M 26372 B/L nasal epistaxis 
Poorly differentiated 
squamous cell 
carcinoma T4N2M0 Chemo-Radiation 
37 Rajammal 55/F 22089 Right headache 
well differentiated 
squamous cell 
carcinoma T3N1M0 Chemo-Radiation 
38 Raju 55/M 55048 Blurring of vision Malignant melanoma T2N1MO 
TOTAL 
MAXILLECTOMY 
39 Gandhiammal 60/F 54436 Right side epistaxis Inverted papilloma  T3NOMO Lateral Rhinotomy 
40 Elizabeth rani 45/F 57546 
B/L nasal 
obstruction Inverted papilloma  T2NOMO Lateral rhinotomy 
41 Shanmugavel 48/M 63175 Right side epistaxis Inverted papilloma  T2NOMO Lateral Rhinotomy 
42 Durairaj 32/M 65309 Left side epistaxis Fungiform papilloma T1NOMO Lateral Rhinotomy 
43 Nagaraj 60/M 58183 Right side epistaxis Angiomatous polyp  -  Excision 
44 Selvi 60/F 24032 Right side epistaxis Squamous papilloma T2NOMO Lateral Rhinotomy 
45 Anandhan 36/M 40552 
B/L nasal 
obstruction Neurofibroma Stage II 
Endoscopic 
excision 
46 Sharmila 30/M 20563 B/L nasal Acinic cell carcinoma T2N0M0 Chemo-Radiation 
obstruction 
47 Senthilvelmurugan 55/M 21394 Right side epistaxis Squamous papilloma T1NOMO Lateral Rhinotomy 
48 Ponmudi 56/M 87261 
B/L nasal 
obstruction 
well differentiated 
squamous cell 
carcinoma T3N1M0 Chemo-Radiation 
49 Sivakumar 45/M 49128 
Left side nasal 
obstruction 
moderately 
differentiated squamous 
cell carcinoma T4N0MX Chemo-Radiation 
50 Kannan 45/M 29171 Right side epistaxis 
Olfactory 
neuroblastoma Stage C 
Palliative Chemo-
Radiation 
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